BioCryst Pharmaceuticals, Inc. (BCRX) Upgraded to "Sell" at BidaskClub
Several other research firms have also commented on BCRX. Noble Financial reaffirmed a buy rating on shares of BioCryst Pharmaceuticals in a report on Saturday, May 6th.
from Biotech News
0 Comments